Accessibility Tools

Source: Healio

Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published in JAMA Surgery.

Know More

Get In Touch

Fields marked (*) are required